球体
组织工程
骨骼肌
细胞外基质
心肌细胞
细胞生物学
生物医学工程
C2C12型
细胞培养
解剖
生物
肌发生
医学
遗传学
作者
Mendy Minne,Lisanne Terrie,Rebecca Wüst,Steffie Hasevoets,Kato Vanden Kerchove,Kakra Nimako,Ivo Lambrichts,Lieven Thorrez,Heidi Declercq
出处
期刊:Biofabrication
[IOP Publishing]
日期:2024-03-04
卷期号:16 (2): 025035-025035
被引量:5
标识
DOI:10.1088/1758-5090/ad2fd5
摘要
Abstract Engineered myogenic microtissues derived from human skeletal myoblasts offer unique opportunities for varying skeletal muscle tissue engineering applications, such as in vitro drug-testing and disease modelling. However, more complex models require the incorporation of vascular structures, which remains to be challenging. In this study, myogenic spheroids were generated using a high-throughput, non-adhesive micropatterned surface. Since monoculture spheroids containing human skeletal myoblasts were unable to remain their integrity, co-culture spheroids combining human skeletal myoblasts and human adipose-derived stem cells were created. When using the optimal ratio, uniform and viable spheroids with enhanced myogenic properties were achieved. Applying a pre-vascularization strategy, through addition of endothelial cells, resulted in the formation of spheroids containing capillary-like networks, lumina and collagen in the extracellular matrix, whilst retaining myogenicity. Moreover, sprouting of endothelial cells from the spheroids when encapsulated in fibrin was allowed. The possibility of spheroids, from different maturation stages, to assemble into a more large construct was proven by doublet fusion experiments. The relevance of using three-dimensional microtissues with tissue-specific microarchitecture and increased complexity, together with the high-throughput generation approach, makes the generated spheroids a suitable tool for in vitro drug-testing and human disease modeling.
科研通智能强力驱动
Strongly Powered by AbleSci AI